APA

Vendrik C. P., Fichtinger-Schepman A. M., van Dijk-Knijnenburg W. C., de Jong W. H., van der Minnen A. C., de Groot G., Berends G. F. & Steerenberg P. A. (19970421). Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts. : Cancer chemotherapy and pharmacology.

Chicago

Vendrik C P, Fichtinger-Schepman A M, van Dijk-Knijnenburg W C, de Jong W H, van der Minnen A C, de Groot G, Berends G F and Steerenberg P A. 19970421. Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts. : Cancer chemotherapy and pharmacology.

Harvard

Vendrik C. P., Fichtinger-Schepman A. M., van Dijk-Knijnenburg W. C., de Jong W. H., van der Minnen A. C., de Groot G., Berends G. F. and Steerenberg P. A. (19970421). Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts. : Cancer chemotherapy and pharmacology.

MLA

Vendrik C P, Fichtinger-Schepman A M, van Dijk-Knijnenburg W C, de Jong W H, van der Minnen A C, de Groot G, Berends G F and Steerenberg P A. Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts. : Cancer chemotherapy and pharmacology. 19970421.